Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022)
Iridex (IRIX) posted quarterly Long-Term Deferred Tax of $80000.0 for Q4 2022, up 220.0% year-over-year from $25000.0 in Q4 2021, and up 220.0% quarter-over-quarter from $25000.0 in Q1 2022.
Iridex (IRIX) Long-Term Deferred Tax (2011 - 2022) Analysis & Trends
Iridex's Long-Term Deferred Tax history runs 6 years deep, the most recent figure standing at $80000.0 for Q4 2022.
- In Q4 2022, Long-Term Deferred Tax rose 220.0% year-over-year to $80000.0; the TTM figure through Dec 2022 stood at $80000.0 (up 220.0% YoY), while the FY2022 annual figure was $80000.0, up 220.0% from the prior year.
- Long-Term Deferred Tax for Q4 2022 stood at $80000.0, up from $25000.0 in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $80000.0 in Q4 2022, with the low at $25000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Iridex | 13.27 Mn | 8.59 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 80,000.00 |
| Jan 1, 2022 | 25,000.00 |
| Oct 1, 2016 | 8.99 Mn |
| Jul 2, 2016 | 8.99 Mn |
| Apr 2, 2016 | 8.99 Mn |
| Jan 2, 2016 | 8.99 Mn |
| Oct 3, 2015 | 7.15 Mn |
| Jul 4, 2015 | 7.15 Mn |
| Apr 4, 2015 | 7.00 Mn |
| Jan 3, 2015 | 7.15 Mn |
| Dec 28, 2013 | 10.00 Mn |
| Dec 29, 2012 | 10.10 Mn |
| Dec 31, 2011 | 11.70 Mn |